Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, Timothy P. Sheahan, William S. Conrad et al.|Science Translational Medicine|2022Cited by 83
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green MonkeysRichard L. Mackman, Tomáš Cihlář, Rao Kalla et al.|Journal of Medicinal Chemistry|2023Cited by 63
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, Timothy P. Sheahan, David R. Martinez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 24
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 that Exhibits Antiviral Efficacy in SARS-CoV-2 Infected African Green MonkeysRichard L. Mackman, Tomáš Cihlář, Rao Kalla et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 11